Genomic tools for Psilocybe cubensis propagation
Kevin McKernan, CSO at Medicinal Genomics will be joining us to discuss genetic variation in the Psilocybe cubensis synthesis pathway and the design of qPCR assays for simultaneous quantification of E. coli and Salmonella species contamination concurrent with Psilocybe cubensis species identification.
Innovations in Disease Modeling 2022
This inaugural online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organ-on-a-chip and organoid models, as well as, how innovations are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.
The Analytical Landscape of Cannabis Testing Session 4: Residual Solvents & Terpenes by GC-MS
In the first part of this webinar, Kirk will talk about headspace sampling and GC-MS measurement of residual solvents using the JEOL JMS-Q1500GC quadrupole GC-MS system, and how the technique can meet California’s minimum reporting limits.
Developing Mass Spectrometry for Deep and Quantitative Single-Cell Proteomics
Dr. Nemes will share developments from his lab that enabled the in situ and in vivo measurement of metabolites and proteins in single cells in live tissues and organisms, while Dr. Orsburn will explain how leaps in mass spectrometry can facilitate unprecedented sequence coverage of protein at the single-cell level.
Opportunities and Challenges of Blood-Based Biomarkers in Alzheimer's Disease
In this webinar, our expert speaker, Professor Lei Liu, Assistant Professor of Neurology from Harvard Medical School will discuss strategies in developing an ultrasensitive immunoassay* to measure oligomeric amyloid β in human plasma precisely.
Reshaping the Lipid Landscape: Using High-Resolution Ion Mobility To Untangle the Lipidome
In this webinar, Dr. Kim Ekroos explains how an HRIM-MS technique based on structures for lossless ion manipulation (SLIM) technology is enabling him to dissect the metabolic glycosphingolipid map in Parkinson’s disease.